Suppr超能文献

心脏手术术后肝移植受者的手术结果。

Surgical outcomes after cardiac surgery in liver transplant recipients.

机构信息

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa.

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa.

出版信息

J Thorac Cardiovasc Surg. 2013 Apr;145(4):1072-1076. doi: 10.1016/j.jtcvs.2012.09.099. Epub 2012 Dec 13.

Abstract

OBJECTIVE

This was a single-center retrospective study to assess the surgical outcomes and predictors of mortality of liver transplant recipients undergoing cardiac surgery.

METHODS

From 2000 to 2010, 61 patients with a functioning liver allograft underwent cardiac surgery. The mean interval between liver transplantation and cardiac surgery was 5.4 ± 4.4 years. Of the 61 patients, 33 (54%) were in Child-Pugh class A and 28 in class B. The preoperative and postoperative data were reviewed.

RESULTS

The overall in-hospital mortality was 6.6%. The survival rate was 82.4% ± 5.1% at 1 year and 50.2% ± 8.2% at 5 years. Cox regression analysis identified preoperative encephalopathy (odds ratio, 5.2; 95% confidence interval, 1.8-15.5; P = .003) and pulmonary hypertension (odds ratio, 3.5; 95% confidence interval, 1.3-9.4; P = .045) as independent predictors of late mortality. The preoperative Model for End-Stage Liver Disease (MELD) scores of patients who died in-hospital or late postoperatively were significantly greater statistically than the scores of the others (in-hospital death, 23.7 ± 7.8 vs 13.1 ± 4.5, P < .001; late death, 15.2 ± 6.1 vs 12.3 ± 4.1, P = .038). The Youden index identified an optimal MELD score cutoff value of 13.5 (sensitivity, 56.0%; specificity, 67.6%). Kaplan-Meier survival analysis successfully demonstrated that the survival rate of the MELD score less than 13.5 (MELD <13.5) group was significantly greater than that of the MELD >13.5 group (MELD <13.5 group, 93.8% ± 4.2% at 1 year and 52.4% ± 11.8% at 5 years; MELD >13.5 group, 66.9% ± 9.6% at 1 year and 46.1% ± 11.1% at 5 years; P = .027). In contrast, the survival rate when stratified by Child-Pugh class (class A vs B) was not significantly different.

CONCLUSIONS

Cardiac surgery in the liver allograft recipients was associated with acceptable surgical outcomes. Preoperative encephalopathy and pulmonary hypertension were independent predictors of late mortality. The cutoff value of 13.5 in the MELD score might be useful for predicting surgical mortality in cardiac surgery.

摘要

目的

本研究旨在评估心脏手术对肝移植受者的手术结果和死亡率的预测因素。

方法

2000 年至 2010 年,61 例肝功能正常的肝移植受者接受了心脏手术。肝移植与心脏手术之间的平均间隔时间为 5.4 ± 4.4 年。61 例患者中,33 例(54%)为 Child-Pugh 分级 A,28 例为分级 B。回顾了术前和术后的数据。

结果

总体住院死亡率为 6.6%。1 年生存率为 82.4% ± 5.1%,5 年生存率为 50.2% ± 8.2%。Cox 回归分析确定术前脑病(优势比,5.2;95%置信区间,1.8-15.5;P =.003)和肺动脉高压(优势比,3.5;95%置信区间,1.3-9.4;P =.045)是晚期死亡的独立预测因素。住院死亡或术后晚期死亡患者的术前终末期肝病模型(MELD)评分明显大于其他患者(住院死亡,23.7 ± 7.8 比 13.1 ± 4.5,P <.001;晚期死亡,15.2 ± 6.1 比 12.3 ± 4.1,P =.038)。Youden 指数确定了 13.5 的最佳 MELD 评分截断值(灵敏度,56.0%;特异性,67.6%)。Kaplan-Meier 生存分析成功表明,MELD 评分小于 13.5(MELD <13.5)组的生存率明显大于 MELD 评分大于 13.5(MELD <13.5)组(MELD <13.5 组,1 年时为 93.8% ± 4.2%,5 年时为 52.4% ± 11.8%;MELD >13.5 组,1 年时为 66.9% ± 9.6%,5 年时为 46.1% ± 11.1%;P =.027)。相比之下,根据 Child-Pugh 分级(A级与 B 级)分层的生存率无显著差异。

结论

心脏手术在肝移植受者中具有可接受的手术结果。术前脑病和肺动脉高压是晚期死亡的独立预测因素。MELD 评分中的 13.5 截断值可能有助于预测心脏手术的手术死亡率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验